A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a ...
MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...
MedPage Today on MSN
Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest
Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic ...
Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...
Our top 10 ALS news stories of 2025 feature actor Eric Dane’s advocacy and major research milestones in the field.
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...
New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...
10monon MSN
Progress spurred by ALS Ice Bucket Challenge — and what remains to be done 10 years later
Last month the ALS Ice Bucket Challenge celebrated its 10th anniversary. The fundraising idea was the brainchild of both the ...
A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback